Skip to content
Info@spinogenix.comMonday – Friday 10 AM – 8 PM
Linkedin page opens in new windowX page opens in new windowInstagram page opens in new windowVimeo page opens in new windowYouTube page opens in new window
Spinogenix
Restoring Synaptic Function Starts Today
SpinogenixSpinogenix
  • About
    • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
  • Pipeline
  • Patients
    • Patients
    • Expanded Access Policy
  • Media
    • Press Releases
    • In The News
    • Blog
  • Contact
Search:
  • About
    • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
  • Pipeline
  • Patients
    • Patients
    • Expanded Access Policy
  • Media
    • Press Releases
    • In The News
    • Blog
  • Contact

Alzheimer’s Disease (AD)

Using EEG and TMS to capture treatment-related Brain Signals in Spinogenix Drug Trials

By daveFebruary 6, 2024

Drug development is a complicated, expensive, and time-consuming activity that requires thoughtful application of scientific and medical principles to bring the best possible treatments forward to affected patients. In general terms, to improve our ability to quickly advance potential treatments through the early phases of clinical evaluation, we need to improve how we measure drug…

←12←
©2026. Spinogenix, Inc. All rights reserved.    |   Privacy Policy   |   Accessibility Policy   |   Disclaimer   |   EAP   |   
Website developed by Insight Designs Web Solutions, LLC
Go to Top